As countries around the world prepare for approving and rolling out Covid-19 vaccines, a group of experts is raising concerns that many governments are not publishing important data about Covid-19 and gender. Evidence is emerging of differences between women and men in terms of testing, hospitalizations and deaths. “The three leading vaccines haven’t recorded their results according to gender, which is problematic”, says Professor Kent Buse, co-founder of Global Health 50/50.
Demands for more Covid-19 vaccine transparency grow as studies ‘were problematically gender-blind’
